NCT07176494 Revision of Deep Brain Stimulator in Patients With Parkinson's Disease
| NCT ID | NCT07176494 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Etlik City Hospital |
| Condition | Pain Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-09-20 |
| Primary Completion | 2026-07-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-09-20 with a primary completion date of 2026-07-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Parkinson's disease is a chronic and progressive neurodegenerative disease that affects the central nervous system, particularly impairing movement control. It is associated with the loss of dopamine-producing cells in the brain and typically occurs in middle age and beyond. Deep brain stimulation (DBS) is considered when symptoms of Parkinson's disease, such as tremors, slowed movements, and muscle rigidity, are not adequately controlled with medications. Selected patients with severe symptoms that do not respond to medical treatment are generally considered for this treatment. Battery revision surgeries can be performed under general anesthesia or regional anesthesia. Patients undergoing general anesthesia should be cautious about the potential complications of general anesthesia, while those undergoing regional anesthesia should be cautious about the local anesthetic systemic toxicity. Because each method has its own advantages, the choice of anesthesia may vary. This study aimed to compare postoperative analgesic efficacy and patient satisfaction in patients who underwent surgery under general anesthesia or sedation-assisted battery replacement under regional anesthesia. Both anesthesia methods are routinely used in Parkinson's disease patients undergoing battery replacement.
Eligibility Criteria
Inclusion Criteria: * Those aged 40-85 * Those with an ASA score of I-II-III * Those with a body mass index (BMI) between 18-30 Exclusion Criteria: * Those under 40 and over 85 * Those with an ASA score of IV or higher * Those with a BMI of under 18 and over 30
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07176494 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 85 Years, studying Pain Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07176494 currently recruiting?
Yes, NCT07176494 is actively recruiting participants. Contact the research team at ibrahimtpc78@gmail.com for enrollment information.
Where is the NCT07176494 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07176494 clinical trial?
NCT07176494 is sponsored by Ankara Etlik City Hospital. The trial plans to enroll 50 participants.